Table 1 Patients characteristics (n = 48)
From: Up-regulation and clinical relevance of novel helicase homologue DHX32 in colorectal cancer
| Â | n (%) |
|---|---|
Age (year) | Â |
   <59 | 25(52.1) |
   ≥ 59 | 23(47.9) |
Gender | Â |
   Male | 22(45.8) |
   Female | 26(54.2) |
Tumor Location | Â |
   Colon | 10(20.8) |
   Rectum | 38(79.2) |
Polypi | Â |
   + | 14(29.2) |
   - | 34(70.8) |
Lymph metastases | Â |
   + | 27(56.3) |
   - | 21(43.7) |
Tumor Nodal | Â |
   + | 20(41.7) |
   - | 28(58.3) |
Tumor Differentiation | Â |
   Poor | 9(18.8) |
   Median + WELL | 39(81.2) |
Dukes, Stage | Â |
   A+B | 21(43.8) |
   C+D | 27(56.2) |